Torigen Pharmaceuticals
Farmington, US · Delaware corporation · 7 known investors
Biotech
Founders & leadership
AK
Ashley KalinauskasFounder30 Under 30 2020
MS
Mark SuckowNamed on SEC filing
BP
Brad PoffNamed on SEC filing
TD
Terry DewNamed on SEC filing
Investors · 7
Chloe CapitalIthaca · $100K – $250K
Connecticut InnovationsNew Haven · $500K – $2M
Emerald Development ManagersNew York
Launchpad Venture GroupBoston · $8M – $10M
__Twitter.png)
GaingelsreportedNew York · $200K – $500K
SoGal Venturesreported · 3 sourcesNew York · $50K – $500Kvia Elizabeth Galbut · board
The FundreportedAustin · $50K – $250K
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 4 rounds · 2019–2022
▶$4.6MraisedMay 2022 · 30 investors · PharmaceuticalsRule 506(b)
▶$4.6MraisedMay 2022 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Blake HawleyDirector
- Kevin CrowleyDirector
- John KallassyExecutive Officer
- Musan DuricDirector
- Ashley KalinauskasExecutive Officer, Director
- Elizabeth GalbutDirector
- Offering amount
- $10M
- Amount sold
- $4.6M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedDec 2021 · 16 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedDec 2021 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer, Director
- Kevin CrowleyDirector
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Blake HawleyDirector
- Elizabeth GalbutDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMar 2021 · 38 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedMar 2021 · 38 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer, Director
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Elizabeth GalbutDirector
- Kevin CrowleyDirector
- Blake HawleyDirector
- Offering amount
- $3.5M
- Amount sold
- $3.3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJan 2019 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedJan 2019 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer
- Mark SuckowExecutive Officer, Director
- Brad PoffExecutive Officer
- Terry DewExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapPetcure Oncology10 shared keywordsPetCure Oncology provides comprehensive cancer care for dogs and cats, including advanced stereotactic radiation therapy (SRS/SRT), delivered through board-certified veterinary oncologists and specialists. It partners with veterinarians across the country to give pet parents access to non-surgical cancer treatment options.
Vcahospitals9 shared keywordsVCA Animal Hospitals operates a network of veterinary clinics offering pet exams, preventive care, specialty and emergency services, and CareClub preventive health care membership plans for dog and cat owners. It also provides parasite prevention, dental checks, vaccinations, and specialty consultations across participating US locations.
Wagwalking9 shared keywordsWag! is a marketplace that connects pet owners with local pet caregivers for services including dog walking, drop-in visits, pet sitting, and boarding. The platform vets caregivers through background checks and provides real-time updates and communication tools for pet owners to monitor their pets during service.
Companies competing with Torigen Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who founded Torigen Pharmaceuticals?
- Torigen Pharmaceuticals was founded by Ashley Kalinauskas.
- Who are Torigen Pharmaceuticals's investors?
- Torigen Pharmaceuticals's investors include Chloe Capital, Connecticut Innovations, Emerald Development Managers, Launchpad Venture Group, Gaingels, SoGal Ventures, The Fund.
- How much funding has Torigen Pharmaceuticals raised?
- Torigen Pharmaceuticals has disclosed $10.9M raised across 4 rounds.
- Where is Torigen Pharmaceuticals headquartered?
- Torigen Pharmaceuticals is headquartered in Farmington, US.